Genetic testing startup 23 and May, who filed for bankruptcy earlier this year, Announced On Monday, he agreed to sell the genetic data of his 15 million consumers to its basic business, as well as the drug developer to Region Pharmaceuticals. This acquisition, which is worth $ 256 million after bankruptcy auction, is expected to close in the third quarter of this year.
Regner, told users of 23 and in the 23rd and the privacy policy, which could urge users to delete their personal information.
Related: ‘Surprised and frustrated’: 23 and all independent board members resign, leaving only CEO
“We assure clients and customers that we are committed to protecting 23 and Dataset,” Regionron Genitics Center chief Ers Barris, Said in a press release.
Baras explained that the Regioneron Genitics Center has a genetic data experience, which has led to the process of genetic information of nearly three million people in research studies that was the case. Established in 2013. Barrus said “Regional has shared the vision of the power of genetics and data.”
The acquisition of Regenron contains 23 and May’s personal genome service, which conducts DNA testing for genetic forecasts, lineages and properties based on a small wholesale sample. Under this acquisition, 23 and the mayors will continue their daily operations as a personal genomics service, but will continue to offer genetic testing as a subsidiary of Region.
Ann Wojki. Picture of Cindy Red/VF 24/Getty Images for Vanity Fair
Related: ‘Hard but necessary’: 23 and I cut 40 % of my workforce
23 and the only part of the business of the business that the pursuit of it does not cover is the television division, Lemonide HealthWho plans to plan 23 more. The company’s staff in other divisions other than Liminated Health, the number around it 300 employeesKeep your jobs.
For the Eastern District Missouri, the US bankruptcy court has still approved the agreement by a judge monitoring bankruptcy.
Filled at the end of March 23 and after a few years for bankruptcy. Company’s reputation hit a hit after an Data violation in 2023 Exposed the data of about seven million people, or half of the company. 23 and mi Million agreed to pay 30 million In September to set the case for the violation, but data confidentiality has led to concern.
23 and founder Ann Wojki, 51, Resigned After news of bankruptcy, 23 and Mai as the CEO but continued to serve in the company’s board of directors. Wojcicki, who Co -founder 23 and m In 2006 and Owns 49 % About the company, he said he resigned from the CEO’s role to be “in the best position” to bid the company for total ownership.
Wojki offered some rejected tips for buying 23 and mi, In a July 2024 And Another February To buy all the company’s shares that they were already in cash at $ 2.53 for the Equity Value of.574.7 million.
In September, all the Independent Directors of 23 and May Resigned from the board Due to strategic differences with Wozki. Since then they are Has been replaced. The company kept 40 % of its manpower or more than 200 people in November to reduce costs.
23 and mi Went public In 2021 and had the price About $ 6 billion dollars At the height this year
Related: Silicon Valley’s Panier and former YouTube CEO Susan Wojki died at the age of 56 – how he changed the tech industry here.
Genetic testing startup 23 and May, who filed for bankruptcy earlier this year, Announced On Monday, he agreed to sell the genetic data of his 15 million consumers to its basic business, as well as the drug developer to Region Pharmaceuticals. This acquisition, which is worth $ 256 million after bankruptcy auction, is expected to close in the third quarter of this year.
Regner, told users of 23 and in the 23rd and the privacy policy, which could urge users to delete their personal information.
Related: ‘Surprised and frustrated’: 23 and all independent board members resign, leaving only CEO
The rest of this article is locked.
Join the business+ To reach today.